TARU PUBLICATIONS
COLLNET Journal of Scientometrics and Information Management cover

COLLNET Journal of Scientometrics and Information Management

(Since 2007)
Hybrid ·Peer-reviewed·ISSN (Online): 2168-930X·ISSN (Print): 0973-7766

WoS  JIF 2026 : 0.6 (Q3)

Powered by:Powered by

Half-Yearly Journal: Publishes research and articles on scientometrics and information management, including bibliometric analysis and quality assurance models.

Issues up to 2022 co-published with and available at:Taylor & Francis Online
EDITOR-CJSIM@tarupublications.com
Taru Online First Current IssueBrowse all Issues
COLLNET Journal of Scientometrics and Information Management
Open Access Research Article

Exploration of scientific insight of gut-brain axis research trends through computational investigation

, , , *

* Corresponding author · click or hover a name for details

pp. 1–20Vol. 19Issue 1June 2025DOI: 10.47974/CJSIM-2023-0107XML
Published Online:
01 Jul 2025
Article type:
Research Article
Language:
EN
Article no.:
CJSIM-2023-0107
Pages:
1–20

Abstract

The gut-brain axis, a vital bidirectional communication system between the central nervous system and the gastrointestinal tract, is crucial for maintaining homeostasis. Dysregulation of this axis, influenced by factors like gut microbiota, neurotransmitters, and dietary patterns, is associated with various health conditions. This study presents a comprehensive bibliometric analysis of gut-brain axis (GBA) research. This study utilizes co-word cluster network analysis on 16062 publications from the Web of Science database to understand the thematic evolution of gut-brain axis studies. The top 20 countries, organizations, authors, journals and WoS micro topics were identified along with their publication impact in terms of average citation and h-index, were also analysed using the Bibliometrix-Biblioshiny package in R software. The findings show significant growth in publications that indicates the increasing importance of gut-brain axis research. Thematic analysis reveals a shift from microbiota characterization to metabolic, immune, and neuroinflammatory pathways, emphasizing translational applications such as probiotics and fecal microbiota transplantation (FMT). The increasing focus on neurodegenerative and psychiatric disorders emphasize the interdisciplinary nature of GBA research, spanning neuroscience, microbiology, and immunology.

Keywords

Gut-brain axisWoS micro topicsGI tractCentral nervous systemBibliometrics

References

[1] B. Bonaz, “Is physical activity possible and beneficial for Le patients with C receiving pegylated axis hepatitis dysfunction interferon and ribavarin therapy ? L ’ activité physique est-elle possible et bénéfique chez les malades atteints d ’ hépatite chronique C t,” Gastroentérologie Clin. Biol., vol. 33, pp. S48–S58 (2009), doi: 10.1016/S0399-8320(09)71525-8.
[2] A. Mulak and B. Bonaz, “Irritable bowel syndrome : a model of the brain-gut interactions,” vol. 10, no. 4, pp. 55–63 (2004).
[3] G. Tougas, “The autonomic nervous system in functional bowel disorders,” no. Suppl IV, pp. 78–80 (2000).
[4] E. A. Mayer, B. D. Naliboff, and A. D. B. U. D. Craig, “Neuroimaging of the Brain-Gut Axis : From Basic Understanding to Treatment of Functional GI Disorders,” pp. 1925–1942 (2006), doi: 10.1053/j.gastro.2006.10.026.
[5] E. A. Mayer, “Principles and clinical implications of the brain–gut–enteric microbiota axis,” vol. 6, no. 5 (2009), doi: 10.1038/nrgastro.2009.35.Principles.
[6] K. Rooijers, A. A. Kolmeder, R. A. Juste, H. J. D. Dore, C. de Vos, and S. M. van Hijum, “An iterative workflow for mining the human intestinal metaproteome,” BMC Genomics, vol. 12 (2011), doi: 10.1186/1471-2164-12-6.
[7] L. A. Lobo, C. F. Benjamim, and A. C. Oliveira, “The interplay between microbiota and inflammation: lessons from peritonitis and sepsis,” Clin. Transl. Immunol., vol. 5, no. 7, p. e90 (2016), doi: 10.1038/cti.2016.32.
[8] R. P. Dickson, “The microbiome and critical illness,” Lancet Respir. Med., vol. 4, no. 1, pp. 59–72 (2016), doi: 10.1016/S2213-2600(15)00427-0.
[9] R. Mittal, A. Debs, A. H. Patel, D. Nguyen, R. Patel, J. T. O’Connor, and S. P. Grati, “Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis,” J. Cell. Physiol., vol. 232, no. 9, pp. 2359–2372 (2017), doi: 10.1002/jcp.25518.
[10] A. Emeran, B. D. Naliboff, and L. Chang, “Stress and the Gastrointestinal Tract V. Stress and irritable bowel syndrome,” (2001).
[11] S. Grenham, G. Clarke, J. F. Cryan, and T. G. Dinan, “Brain-gut-microbe communication in health and disease,” Front. Physiol., vol. 2 DEC, no. December, pp. 1–15 (2011), doi: 10.3389/fphys.2011.00094.
[12] L. E. Goehler, M. Lyte, and R. P. A. Gaykema, “Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology,” vol. 21, no. 6, pp. 721–726 (2007).
[13] L. E. Goehler, “Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior,” vol. 22, no. 3, pp. 354–366 (2008).
[14] P. Bercik, E. F. Verdú, M. Verma-Gandhu, X.-X. Huang, P. Blennerhassett, W. Jackson, Y. Mao, L. Wang, F. Rochat, and S. M. Collins, “Specific probiotic therapy attenuates antibiotic,” pp. 182–190 (2006), doi: 10.1136/gut.2005.066100.
[15] D. P. McKernan, P. Fitzgerald, T. G. Dinan, and J. F. Cryan, “The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat,” Neurogastroenterol. Motil., vol. 22, no. 9, pp. 1029–1036 (2010), doi: 10.1111/j.1365-2982.2010.01520.x.
[16] R. Linares, F. A. Leve, M. K. Jah, and J. L. Crassidis, “Space object mass-specific inertia matrix estimation from photometric data,” Adv. Astronaut. Sci., vol. 144, pp. 41–54, 2012, doi: 10.1038/nature4441021a.
[17] N. Larsen, F. K. Vogensen, F. W. J. van den Berg, D. S. Nielsen, A. S. Andreasen, B. K. Pedersen, W. A. Al-Soud, S. J. Sørensen, L. H. Hansen, and M. Jakobsen, “Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults,” PLoS One, vol. 5, no. 2 (2010), doi: 10.1371/journal.pone.0009085.
[18] Y. P. Silva, A. Bernardi, and R. L. Frozza, “The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication,” Front. Endocrinol. (Lausanne)., vol. 11, no. January, pp. 1–14 (2020), doi: 10.3389/fendo.2020.00025.
[19] M. M. Unger, J. Spiegel, K.-U. Dillmann, D. Grundmann, H. Philippeit, J. Bürmann, K. Faßbender, A. Schwiertz, and K.-H. Schäfer, “Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls,” Park. Relat. Disord., vol. 32, pp. 66–72 (2016), doi: 10.1016/j.parkreldis.2016.08.019.
[20] V. Caputi and M. C. Giron, “Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease.,” Int. J. Mol. Sci., vol. 19, no. 6 (Jun. 2018), doi: 10.3390/ijms19061689.
[21] M. Bostanciklioğlu, “The role of gut microbiota in pathogenesis of Alzheimer’s disease,” J. Appl. Microbiol., vol. 127, no. 4, pp. 954–967 (2019), doi: 10.1111/jam.14264.
[22] F. Angelucci, K. Cechova, J. Amlerova, and J. Hort, “Antibiotics, gut microbiota, and Alzheimer’s disease,” J. Neuroinflammation, vol. 16, no. 1, pp. 1–10 (2019), doi: 10.1186/s12974-019-1494-4.
[23] Q. Kong, “Antimicrobial Peptides : Classification , Design , Application and Research Progress in Multiple,” vol. 11, no. October, pp. 1–21 (2020), doi: 10.3389/fmicb.2020.582779.
[24] L. Ho, K. Ono, M. Tsuji, P. Mazzola, R. Singh, and G. M. Pasinetti, “Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms,” Expert Rev. Neurother., vol. 18, no. 1, pp. 83–90 (2018), doi: 10.1080/14737175.2018.1400909.
[25] Y. Zhao, L. Cong, V. Jaber, and W. J. Lukiw, “Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer’s disease brain,” Front. Immunol., vol. 8, no. SEP, pp. 1–6 (2017), doi: 10.3389/fimmu.2017.01064.
[26] L. Zhang, Y. Wang, X. Xiayu, C. Shi, W. Chen, N. Song, X. Fu, R. Zhou, Y. Xu, L. Huang, and A. Li, “Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease.,” J. Alzheimers. Dis., vol. 60, no. 4, pp. 1241–1257 (2017), doi: 10.3233/JAD-170020.
[27] N. M. Vogt, K. A. Romano, B. F. Darst, C. D. Engelman, S. C. Johnson, C. M. Carlsson, S. Asthana, K. Blennow, H. Zetterberg, B. B. Bendlin, and F. E. Rey, “The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease,” Alzheimer’s Res. Ther., vol. 10, no. 1, pp. 1–8 (2018), doi: 10.1186/s13195-018-0451-2.
[28] E. E. Noble, T. M. Hsu, and S. E. Kanoski, “Gut to brain dysbiosis: Mechanisms linking western diet consumption, the microbiome, and cognitive impairment,” Front. Behav. Neurosci., vol. 11, no. January, pp. 1–10 (2017), doi: 10.3389/fnbeh.2017.00009.
[29] T. Sen, C. R. Cawthon, B. T. Ihde, A. Hajnal, P. M. DiLorenzo, C. B. de La Serre, and K. Czaja, “Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity HHS Public Access Author manuscript,” Physiol Behav, vol. 173, pp. 305–317 (2017), doi: 10.1016/j.physbeh.2017.02.027.Diet-driven.
[30] R. Xiu, Q. Sun, B. Li, and Y. Wang, “Mapping Research Trends and Hotspots in the Link between Alzheimer’s Disease and Gut Microbes over the Past Decade: A Bibliometric Analysis,” Nutrients, vol. 15, no. 14 (2023), doi: 10.3390/nu15143203.
[31] X. Zhu, J. Hu, S. Deng, Y. Tan, C. Qiu, M. Zhang, X. Ni, H. Lu, Z. Wang, L. Li, H. Chen, S. Huang, T. Xiao, D. Shang, and Y. Wen, “Bibliometric and Visual Analysis of Research on the Links Between the Gut Microbiota and Depression From 1999 to 2019,” Front. Psychiatry, vol. 11 (2021), doi: 10.3389/fpsyt.2020.587670.
[32] S. H. Zyoud, S. Smale, W. S. Waring, W. M. Sweileh, and S. W. Al-Jabi, “Global research trends in microbiome-gut-brain axis during 2009–2018: a bibliometric and visualized study,” BMC Gastroenterol., vol. 19, no. 1, p. 158 (2019), doi: 10.1186/s12876-019-1076-z.
[33] J. Yang, Y. Deng, Y. Cai, Y. Liu, L. Peng, Z. Luo, and D. Li, “Mapping trends and hotspot regarding gastrointestinal microbiome and neuroscience: A bibliometric analysis of global research (2002–2022),” Front. Neurosci., vol. 16 (2022), doi: 10.3389/fnins.2022.1048565.
[34] C. Yang, X. Lin, X. Wang, H. Liu, J. Huang, and S. Wang, “The schizophrenia and gut microbiota: A bibliometric and visual analysis,” Front. Psychiatry, vol. 13 (2022), doi: 10.3389/fpsyt.2022.1022472.
[35] C. L. Shan, C. J. Fei, W. Ming, K. P. Yan, and Z. X. Ping, “Analyzing the bibliometrics of brain-gut axis and Parkinson’s disease,” Front. Neurol., vol. 15 (2024), doi: 10.3389/fneur.2024.1343303.
[36] K. Pane, S. Boccella, F. Guida, M. Franzese, S. Maione, and M. Salvatore, “Role of gut microbiota in neuropathy and neuropathic pain states: A systematic preclinical review.,” Neurobiol. Dis., vol. 170, p. 105773 (Aug. 2022), doi: 10.1016/j.nbd.2022.105773.
[37] Z. Lan, X. Tang, M. Lu, Z. Hu, and Z. Tang, “The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions,” Heliyon, vol. 10, no. 4, p. e26377 (2024), doi: https://doi.org/10.1016/j.heliyon.2024.e26377.
[38] P.-N. Wu, S. Xiong, P. Zhong, W.-Q. Yang, M. Chen, and T.-C. Tang, “Global trends in research on irritable bowel syndrome and the brain–gut axis: Bibliometrics and visualization analysis,” Front. Pharmacol., vol. 13 (2022), doi: 10.3389/fphar.2022.956204.
[39] M. Mao, Y. Zhou, Y. Jiao, S. Yin, C. Cheung, W. Yu, P. Gao, and L. Yang, “Bibliometric and visual analysis of research on the links between the gut microbiota and pain from 2002 to 2021,” Front. Med., vol. 9 (2022), doi: 10.3389/fmed.2022.975376.

Views: 237Downloads: 42Citations: 0